Advisory Research’s Allergan Inc AGN Stock Holding History

Advisory Research’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-544	Closed	-$68K	–	807
2014 Q1	$68K	Buy	+544	New	+$66.2K	﹤0.01%	650

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisory Research's AGN Position: Q2 2014 in Review

Advisory Research sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 544 shares — an estimated $68K sold.

Advisory Research first reported a position in AGN in Q1 2014 and held it in 1 quarter. The position peaked at $68K in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Advisory Research reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
Advisory Research sold 544 Allergan Inc shares in Q2 2014, an estimated $68K.
Advisory Research first reported a position in Allergan Inc in Q1 2014 and held it in 1 quarter.
Advisory Research's Allergan Inc position peaked at $68K in Q1 2014.
770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Advisory Research's 13F filing for Q2 2014, filed 14 Aug 2014.